8% Off
Wedica100 mg
Beacon Pharmaceuticals PLC
৳4843.80
Out Of Stock
Generic medicine
Trelagliptin Succinate: Brands, Price & Uses in Bangladesh
Approved Use Trelagliptin Succinate is a long-acting, once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with…
About Trelagliptin Succinate
Indications of Trelagliptin Succinate
Approved Use
Trelagliptin Succinate is a long-acting, once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is approved and marketed in Japan (and in a limited number of other Asian markets) rather than by the US FDA, so its regulatory status and availability outside those markets, including Bangladesh, should be confirmed locally before use.
Use in Combination Therapy
Trelagliptin Succinate may be used as monotherapy or in combination with other classes of antidiabetic agents (for example, metformin, sulfonylureas, thiazolidinediones, or insulin) when diet, exercise, and a single agent do not achieve adequate glycemic control, under physician supervision.
Not Indicated For
Trelagliptin Succinate is not indicated for the treatment of type 1 diabetes mellitus or for diabetic ketoacidosis, and it is not a substitute for insulin in patients who require insulin.
Dosage & Administration of Trelagliptin Succinate
Adult Dose (Type 2 Diabetes Mellitus)
| Population | Recommended Dose |
|---|---|
| Adults, standard dose | Trelagliptin Succinate 100 mg orally once weekly, taken on the same day each week |
| Moderate to severe renal impairment | Dose reduction (e.g., to 50 mg once weekly) may be required; see Use in Special Populations and consult the prescribing physician |
Missed Dose
If a weekly dose of Trelagliptin Succinate is missed, it should be taken as soon as remembered on the same day, but a missed dose should not be doubled up close to the next scheduled weekly dose; patients should consult their physician or pharmacist for specific instructions, since the long dosing interval makes missed/duplicate dosing errors more consequential than with daily agents.
Pediatric Dose
Not established; see Pediatric Uses.
Side Effects of Trelagliptin Succinate
Common
- Nasopharyngitis (common cold-like symptoms)
- Gastrointestinal effects such as constipation, abdominal discomfort, or diarrhea
- Headache
- Hypoglycemia (mainly when combined with insulin or sulfonylureas — see Interactions)
Less Common but Clinically Important
- Acute pancreatitis — a rare but serious adverse effect reported with the DPP-4 inhibitor class; see Precautions and Warnings.
- Severe joint pain — reported with DPP-4 inhibitors as a class, sometimes severe or disabling; see Precautions and Warnings.
- Bullous pemphigoid and other skin reactions — rare, class-associated; see Precautions and Warnings.
- Signs of heart failure (e.g., swelling, unusual shortness of breath, rapid weight gain) — reported with some agents in the DPP-4 inhibitor class; see Precautions and Warnings.
Contraindications of Trelagliptin Succinate
Trelagliptin Succinate is contraindicated in patients with:
- Known hypersensitivity to Trelagliptin Succinate or any component of the formulation, including history of serious hypersensitivity reactions (e.g., anaphylaxis, angioedema) to Trelagliptin Succinate or other DPP-4 inhibitors.
- Type 1 diabetes mellitus or diabetic ketoacidosis — Trelagliptin Succinate is not indicated and should not be used in these settings.
Frequently Asked Questions about Trelagliptin Succinate
What is Trelagliptin Succinate used for?
Trelagliptin Succinate is a once-weekly oral medicine used, along with diet and exercise, to help control blood sugar levels in adults with type 2 diabetes mellitus. It is not used for type 1 diabetes.
How often do I need to take Trelagliptin Succinate?
Trelagliptin Succinate is taken only once a week, on the same day each week, which is different from many other diabetes tablets that are taken daily. Choosing a fixed day and using a reminder can help you avoid missing a dose or accidentally taking an extra one.
Can Trelagliptin Succinate cause low blood sugar (hypoglycemia)?
On its own, Trelagliptin Succinate has a relatively low risk of causing hypoglycemia because it works in a glucose-dependent way. However, if you also take insulin or a sulfonylurea medicine, the combined risk of hypoglycemia is higher, and your doctor may need to lower the dose of those other medicines.
What serious side effects should I watch for with Trelagliptin Succinate?
Seek medical attention if you develop persistent severe abdominal pain (possible pancreatitis), new or worsening severe joint pain, blistering or peeling skin (possible bullous pemphigoid), or symptoms like unusual shortness of breath or rapid swelling/weight gain (possible signs of heart failure). Trelagliptin Succinate should be stopped and a doctor consulted promptly if any of these occur.
Is Trelagliptin Succinate safe during pregnancy or breastfeeding?
Data on Trelagliptin Succinate in pregnancy and breastfeeding are limited. It should be used in pregnancy only if clearly needed and if the benefit outweighs the potential risk, and a decision about breastfeeding while using Trelagliptin Succinate should be made together with your physician.
Is Trelagliptin Succinate available everywhere?
Trelagliptin Succinate was developed for once-weekly dosing and is approved and marketed mainly in Japan and a few other Asian markets rather than globally; it has not been approved by the US FDA. Availability may be limited compared to daily DPP-4 inhibitors, so check with your local pharmacy or physician about access in your country.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.